NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

CERT

Certara Inc

Jun 30 • 04:00PM ET

11.70

Dollar change +0.32
Percentage change 2.81	%

Healthcare • Health Information Services • USA • NASD

Peers: IQV CRL ICLR CERS MEDP QDEL PDCO HCM XERS

| Held by: IJR VTI VB VXF VBK DFAT IJS SPSM SLYV SCHA

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.02	Insider Own	26.29%	Shs Outstand	161.48M	Perf Week	11.85%
Market Cap	1.90B	Forward P/E	23.37	EPS next Y	0.50	Insider Trans	0.00%	Shs Float	119.58M	Perf Month	2.63%
Enterprise Value	2.03B	PEG	-	EPS next Q	0.09	Inst Own	74.66%	Short Float	7.49%	Perf Quarter	18.06%
Income	-2.62M	P/S	4.81	EPS this Y	-8.27%	Inst Trans	5.28%	Short Ratio	4.13	Perf Half Y	9.35%
Sales	394.50M	P/B	1.74	EPS next Y	21.28%	ROA	-0.17%	Short Interest	8.96M	Perf YTD	9.86%
Book/sh	6.71	P/C	10.60	EPS next 5Y	5.04%	ROE	-0.25%	52W High	16.93 -30.89%	Perf Year	-16.07%
Cash/sh	1.10	P/FCF	20.65	EPS past 3/5Y	5.33% -5.78%	ROIC	-0.19%	52W Low	8.64 35.50%	Perf 3Y	-47.23%
Dividend Est.	-	EV/EBITDA	22.24	Sales past 3/5Y	10.42% 13.06%	Gross Margin	46.43%	Volatility	4.35% 4.51%	Perf 5Y	-
Dividend TTM	-	EV/Sales	5.14	EPS Y/Y TTM	95.72%	Oper. Margin	5.32%	ATR (14)	0.51	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	2.78	Sales Y/Y TTM	9.37%	Profit Margin	-0.67%	RSI (14)	55.84	Recom	2.08
Dividend Gr. 3/5Y	- -	Current Ratio	2.78	EPS Q/Q	200.00%	SMA20	4.02%	Beta	1.44	Target Price	15.78
Payout	-	Debt/Eq	0.29	Sales Q/Q	9.67%	SMA50	-2.62%	Rel Volume	1.36	Prev Close	11.38
Employees	1546	LT Debt/Eq	0.28	Earnings	May 05 AMC	SMA200	1.26%	Avg Volume	2.17M	Price	11.70
IPO	Dec 11, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	23.78% 0.86%	Trades		Volume	2,953,390	Change	2.81%

Date	Action	Analyst	Rating Change	Price Target Change
May-08-25	Upgrade	Barclays	Equal Weight → Overweight	$14
Feb-27-25	Initiated	TD Cowen	Buy	$16
Sep-27-24	Upgrade	UBS	Neutral → Buy	$16
Apr-10-24	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight	$23
Apr-04-24	Initiated	JMP Securities	Mkt Perform
Feb-26-24	Initiated	Leerink Partners	Market Perform	$19
Dec-07-23	Initiated	UBS	Neutral	$17
Dec-05-23	Initiated	KeyBanc Capital Markets	Sector Weight
Aug-22-23	Downgrade	Jefferies	Buy → Hold	$24.50 → $17
Aug-10-23	Downgrade	William Blair	Outperform → Mkt Perform
Apr-12-23	Initiated	Stephens	Overweight	$28
Apr-03-23	Downgrade	Barclays	Overweight → Equal Weight	$25
Dec-14-22	Downgrade	Robert W. Baird	Outperform → Neutral	$17 → $19
Sep-08-22	Initiated	Berenberg	Buy	$23
Aug-25-22	Initiated	Credit Suisse	Outperform	$22
Jul-01-22	Initiated	Piper Sandler	Overweight	$28
Jan-11-22	Upgrade	Jefferies	Hold → Buy	$31
Aug-05-21	Resumed	Credit Suisse	Neutral	$36
Jul-23-21	Initiated	Robert W. Baird	Outperform	$30
Mar-03-21	Initiated	Barclays	Overweight	$40

Show Previous Ratings

Jun-28-25 09:10AM	10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential (Motley Fool)
Jun-20-25 08:25AM	Will AI Tools Like DocsGPT Drive the Next Leg of Growth for DOCS? (Zacks)
May-23-25 09:17AM	AI Could Add $461 Billion to Global Healthcare--And These New Platforms Are Leading the Charge (PR Newswire)
May-06-25 08:31AM	Q1 2025 Certara Inc Earnings Call (Thomson Reuters StreetEvents) -11.03%
03:09AM	Certara Inc (CERT) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
07:22PM	Loading…
May-05-25 07:22PM	Certara, Inc. (CERT) Q1 2025 Earnings Call Transcript (Seeking Alpha)
05:45PM	Certara, Inc. (CERT) Q1 Earnings and Revenues Beat Estimates (Zacks)
04:15PM	Certara Reports First Quarter 2025 Financial Results (GlobeNewswire)
Apr-29-25 04:15PM	Certara to Participate in Upcoming Investor Conferences (GlobeNewswire)
10:01AM	Sarepta Therapeutics (SRPT) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Apr-28-25 10:00AM	Certara, Inc. (CERT) Earnings Expected to Grow: Should You Buy? (Zacks)
Apr-21-25 08:00AM	3 Momentum Stocks That Could Soar Post-Market Volatility (MarketBeat)
Apr-16-25 12:10PM	Will Certara (CERT) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Apr-15-25 12:40AM	Why Certara Inc. (CERT) Skyrocketed On Monday? (Insider Monkey)
Apr-14-25 08:15AM	Certara Launches Non-Animal Navigator Solution to Help Drug Developers Reduce Reliance on Animal Testing (GlobeNewswire) +11.54%
08:00AM	Loading…
08:00AM	Certara Reports Preliminary First Quarter 2025 Financial Results; Announces $100 Million Share Repurchase Authorization (GlobeNewswire)
Apr-12-25 06:45PM	Why Certara Inc. (CERT) Soared Last Week? (Insider Monkey)
02:10AM	Why Certara Inc. (CERT) Surged On Friday? (Insider Monkey)
Apr-11-25 01:15PM	Buy Certara After The FDA Announcement (Seeking Alpha) +22.84%
10:04AM	Certara (CERT) Soars 8.0%: Is Further Upside Left in the Stock? (Zacks)
Apr-02-25 12:49PM	Checking Back In On Certara: Unattractive Valuation (Seeking Alpha)
Apr-01-25 08:00AM	Certara Expands the Simcyp Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities (GlobeNewswire)
Mar-06-25 07:58PM	Certara, Inc. (CERT): Among the Cash-Rich Small Cap Stocks To Invest In According To Analysts (Insider Monkey)
Mar-05-25 04:15PM	Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions (GlobeNewswire)
Feb-27-25 07:59AM	Q4 2024 Certara Inc Earnings Call (Thomson Reuters StreetEvents)
02:28AM	Certara Inc (CERT) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Expansions (GuruFocus.com)
Feb-26-25 06:45PM	Certara, Inc. (CERT) Surpasses Q4 Earnings and Revenue Estimates (Zacks)
04:15PM	Certara Reports Fourth Quarter 2024 Financial Results (GlobeNewswire)
Feb-14-25 01:12PM	Certara, Inc. (CERT): Among the Health Information Services Stocks Outpacing the Market in 2025 (Insider Monkey)
Jan-29-25 04:15PM	Certara to Report Fourth Quarter and Full Year 2024 Financial Results on February 26th, 2025 and Participate in Upcoming Investor Conferences (GlobeNewswire)
12:48PM	Loading…
Jan-24-25 12:48PM	Certara Inc. (CERT): Accelerating Drug Development with AI Amid Leerinks Target Price Boost to $13 (Insider Monkey)
Jan-15-25 07:55AM	Certara Reports Preliminary Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire) +11.36%
Jan-02-25 04:15PM	Certara to Participate in the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +5.16%
Dec-06-24 10:02AM	Cautious Spending By Large Biopharma Client Dragged Certara (CERT) in Q3 (Insider Monkey)
Dec-02-24 04:15PM	Certara Showcases 2024 Research Wins With Over 100 Papers Published (GlobeNewswire)
Nov-13-24 09:29AM	Soft Biotech Funding and Cost-Cutting Dragged Certara (CERT) in Q3 (Insider Monkey)
Nov-07-24 10:38AM	Q3 2024 Certara Inc Earnings Call (Thomson Reuters StreetEvents)
02:27AM	Certara Inc (CERT) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Nov-06-24 07:05PM	Certara, Inc. (CERT) Q3 Earnings Surpass Estimates (Zacks) +5.82%
04:15PM	Certara Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Oct-28-24 04:15PM	Certara to Participate in the Stephens Annual Investment Conference (GlobeNewswire)
Oct-16-24 04:15PM	Certara Appoints John Reynders as New Independent Board Member (GlobeNewswire)
Oct-15-24 08:05AM	MaxCyte Appoints Cynthia Collins to its Board of Directors (GlobeNewswire)
Oct-09-24 04:15PM	Certara to Report Third Quarter 2024 Financial Results on November 6th, 2024 (GlobeNewswire)
Oct-02-24 04:15PM	Certara Completes Acquisition of Chemaxon (GlobeNewswire)
Sep-27-24 07:20PM	Final Trade: Certara, Nextera Energy, Knight-Swift Transportation and Lululemon (CNBC TV) +9.81%
Sep-24-24 08:00AM	Certara's Simcyp Consortium Celebrates 25th Anniversary (GlobeNewswire)
Sep-18-24 08:00AM	Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug (GlobeNewswire)
Sep-17-24 11:02AM	Should You Increase Your Holdings in Certara (CERT)? (Insider Monkey)
Aug-28-24 07:03PM	Certara, Inc. (CERT): Among The Best Medical AI Companies (Insider Monkey) -5.24%
Aug-21-24 04:15PM	Certara to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-15-24 04:15PM	Certara Launches Phoenix Version 8.5 Drug Development Software (GlobeNewswire)
Aug-12-24 03:57AM	Heres Why Certara (CERT) Stock Underperformed in Q2 (Insider Monkey)
Aug-07-24 12:25PM	Q2 2024 Certara Inc Earnings Call (Thomson Reuters StreetEvents) -13.59%
Aug-06-24 06:25PM	Certara, Inc. (CERT) Q2 Earnings and Revenues Lag Estimates (Zacks)
04:15PM	Certara Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Jul-09-24 04:45PM	Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio (GlobeNewswire)
Jul-02-24 04:15PM	Certara to Report Second Quarter 2024 Financial Results on August 6th, 2024 (GlobeNewswire)
Jun-17-24 08:00AM	Certara Launches Next Generation CoAuthor Generative AI Regulatory Writing Software (GlobeNewswire)
May-29-24 04:15PM	Certara to Participate in the Jefferies Global Healthcare Conference (GlobeNewswire)
May-21-24 08:00AM	Certara Appoints New Chief Human Resources Officer & General Counsel (GlobeNewswire)
May-09-24 02:45PM	Certara, Inc. (NASDAQ:CERT) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-08-24 01:16PM	Q1 2024 Certara Inc Earnings Call (Thomson Reuters StreetEvents) -7.42%
05:48AM	Certara Q1 Adjusted Earnings Down, Revenue Increases (MT Newswires)
04:13AM	Certara Inc (CERT) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges and ... (GuruFocus.com)
May-07-24 06:40PM	Certara, Inc. (CERT) Q1 Earnings Meet Estimates (Zacks)
05:59PM	Certara Inc (CERT) Q1 2024 Earnings: Mixed Results Amidst Revenue Growth and Net Loss (GuruFocus.com)
04:15PM	Certara Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-06-24 03:19AM	What Makes Certara (CERT) an Attractive Bet? (Insider Monkey)
Apr-16-24 08:00AM	Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform (GlobeNewswire)
Apr-09-24 04:15PM	Certara to Report First Quarter 2024 Financial Results on May 7th, 2024 and Participate in the BofA Securities Healthcare Conference (GlobeNewswire)
Apr-04-24 07:01PM	Insider Sell: President of Drug Dev Solutions at Certara Inc (CERT) Sells Shares (GuruFocus.com) +5.15%
Mar-02-24 08:41AM	Certara, Inc. (NASDAQ:CERT) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-01-24 07:10AM	Q4 2023 Certara Inc Earnings Call (Thomson Reuters StreetEvents) +8.41%
Feb-29-24 06:05PM	Certara, Inc. (CERT) Lags Q4 Earnings Estimates (Zacks)
04:52PM	Certara Inc (CERT) Reports Modest Revenue Growth Amidst Net Loss in Q4 2023 (GuruFocus.com)
04:10PM	Certara Reports Fourth Quarter 2023 Financial Results (GlobeNewswire)
Feb-01-24 04:30PM	Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference (GlobeNewswire)
Jan-31-24 11:03PM	Baillie Gifford Adjusts Position in Certara Inc (GuruFocus.com)
Dec-13-23 04:30PM	Certara Acquires Applied BioMath Expanding Its Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing for Novel Therapies (GlobeNewswire)
Nov-21-23 04:30PM	Certara introduces Simcyp Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development (GlobeNewswire)
Nov-10-23 01:22PM	Certara, Inc. (NASDAQ:CERT) Q3 2023 Earnings Call Transcript (Insider Monkey) +6.72%
Nov-09-23 10:41AM	Q3 2023 Certara Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-08-23 07:15PM	Certara, Inc. (CERT) Q3 Earnings Meet Estimates (Zacks)
04:10PM	Certara Reports Third Quarter 2023 Financial Results (GlobeNewswire)
Oct-31-23 12:00PM	Top 12 Medical AI Companies (Insider Monkey)
Oct-20-23 08:34AM	Are Options Traders Betting on a Big Move in Certara (CERT) Stock? (Zacks)
Oct-11-23 04:15PM	Certara to Report Third Quarter 2023 Financial Results on November 8th, 2023, and participate in the Stephens Annual Investment Conference (GlobeNewswire)
Sep-19-23 08:15AM	Certara Announces 300th Regulatory Submission Milestone Using its Technology-enabled Services and Software (GlobeNewswire)
Sep-13-23 05:01AM	Insider Sell: Leif Pedersen Sells 51,224 Shares of Certara Inc (CERT) (GuruFocus.com)
Aug-29-23 04:15PM	Certara to Participate in Upcoming Investor Conferences (GlobeNewswire)
08:15AM	Certara Simcyp Group Awarded Two New Grants from US FDA (GlobeNewswire)
Aug-23-23 01:43PM	Analysts on Wall Street Lower Ratings for These 10 Stocks (Insider Monkey)
Aug-22-23 02:41AM	4 big analyst cuts: Target slashed to Neutral after Q2 Earnings (Investing.com)
Aug-12-23 08:07AM	Certara, Inc. (NASDAQ:CERT) Consensus Forecasts Have Become A Little Darker Since Its Latest Report (Simply Wall St.)
Aug-11-23 06:09AM	Certara Second Quarter 2023 Earnings: Revenues Disappoint (Simply Wall St.)
Aug-10-23 09:41AM	Q2 2023 Certara Inc Earnings Call (Thomson Reuters StreetEvents) -7.65%
Aug-09-23 04:15PM	Certara Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Aug-03-23 09:00PM	Certara collaborates with Korea Institute of Toxicology to ensure FDA submission-ready SEND dataset (Business Wire)
Aug-02-23 08:55AM	There's Been No Shortage Of Growth Recently For Certara's (NASDAQ:CERT) Returns On Capital (Simply Wall St.)

Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017, and is headquartered in Radnor, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Anhalt Rona	Chief Human Resources Officer	May 30 '25	Option Exercise	0.00	7,146	0	7,146	Jun 02 04:58 PM
Corcoran Daniel	SVP and General Counsel	May 30 '25	Option Exercise	0.00	22,828	0	20,530	Jun 02 04:57 PM
WALSH MATTHEW M	Director	May 21 '25	Option Exercise	0.00	11,928	0	197,559	May 22 05:07 PM
Reynders John V W	Director	May 21 '25	Option Exercise	0.00	10,709	0	10,709	May 22 05:05 PM
Killefer Nancy	Director	May 21 '25	Option Exercise	0.00	11,928	0	36,089	May 22 05:04 PM
Crane Rosemary A	Director	May 21 '25	Option Exercise	0.00	11,928	0	29,915	May 22 05:03 PM
Collins Cynthia	Director	May 21 '25	Option Exercise	0.00	11,928	0	36,089	May 22 05:01 PM
CASHMAN JAMES E III	Chairman	May 21 '25	Option Exercise	0.00	11,928	0	468,440	May 22 05:00 PM
BROSHY ERAN	Chairman	May 21 '25	Option Exercise	0.00	11,928	0	34,951	May 22 04:58 PM
Aspbury Robert	PRESIDENT, PREDICTIVE TECH	Apr 01 '25	Option Exercise	0.00	26,626	0	311,936	Apr 03 04:44 PM
Pedersen Leif E	PRESIDENT, CHIEF COMMERCAL OFF	Apr 01 '25	Option Exercise	0.00	26,626	0	127,669	Apr 03 04:40 PM
Gallagher John E	PRESIDENT, CHIEF COMMERCAL OFF	Apr 01 '25	Option Exercise	0.00	42,486	0	51,731	Apr 03 04:36 PM
Feehery William F	CHIEF EXECUTIVE OFFICER	Apr 01 '25	Option Exercise	0.00	111,393	0	2,354,346	Apr 03 04:32 PM
SMITH PATRICK F	Officer	Apr 02 '25	Proposed Sale	9.73	20,142	195,982		Apr 02 10:57 AM
SMITH PATRICK F	PRESIDENT, DRUG DEV SOLUTIONS	Oct 07 '24	Sale	11.03	5,409	59,661	50,091	Oct 08 04:17 PM
SMITH PATRICK F	PRESIDENT, DRUG DEV SOLUTIONS	Oct 04 '24	Option Exercise	0.00	7,151	0	57,242	Oct 07 04:42 PM
SMITH PATRICK F	Officer	Oct 07 '24	Proposed Sale	11.03	5,409	59,661		Oct 07 09:48 AM
Pedersen Leif E	PRESIDENT, CHIEF COMMERCAL OFF	Sep 09 '24	Sale	11.29	51,224	578,319	99,704	Sep 10 05:01 PM
Pedersen Leif E	Officer	Sep 09 '24	Proposed Sale	11.29	51,224	578,450		Sep 09 04:27 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CERT

Certara Inc

Upgrade your FINVIZ experience